Home | Search | Site Map | Contact Us
IoN Home Bar


21st Century Medicine:
Breakthroughs and Challenges

21st Century Medicine

Programme & Abstracts

(click on title to view abstract of presentation)

Date: 26th November 2008
09.00 - 09.20 Registration
09.20 - 09.30 Welcome and introduction
Ottilia Saxl, CEO, Institute of Nanotechnology
Plenary Session: Frontiers in Nanomedicine

Chair: Ottilia Saxl , CEO, Institute of Nanotechnology, UK
09.30 - 10.10

‘Nanobiotechnology for Development of Therapeutics and Diagnostics: Science and Business Perspectives’

Dr. Mostafa Analoui, Senior Director, Pfizer Global Research and Development

Session 2: Commercialising Nanotechnology – Opportunities and Challenges

Chair: David Tolfree, Vice President of MANCEF, UK   
10.15 - 10.45

‘Successful Commercialization – The Ultimate Goal’

Dr. Robert Mehalso, CEO, Microtec Associates, USA

10.50 - 11.15 Refreshments
11.20 - 11.45

‘Six Disruptive Products in Medical and Biomedical Markets based on MNT’

Dr. Malcolm Wilkinson, Director, Technology For Industry Ltd, UK

11.50 - 12.15

The Medusa® Platform for the Controlled Delivery of Proteins, Peptides, and Molecules

Stephen Willard, Flamel Technologies, France

12.20 - 13.30 Lunch

Session 3: Advances in Tissue Engineering and Regenerative Medicine

Chair: Prof. Tim Hardingham,
Wellcome Trust Centre for Cell Matrix Research, UK

13.30 - 13.55

‘Formation of Bone Form Injectable Biomaterials’

Prof. Jöns Hilborn, Prof. of Polymer Chemistry, Uppsala University, President-Tissue Engineering International and Regenerative Medicine Society

14.00 - 14.25

‘Rapid Engineering of Nano-Fibrous Collagen Tissues:
While-u-wait Bedside
Grafts?’

Prof. Robert Brown, UCL Tissue Repair & Engineering Centre, UK

14.30 - 14.55

‘Patient Benefits from Nanomaterials’

David Farrar, Technology Manager – Biomaterials, Smith & Nephew

15.00 - 15.30 Refreshments

Workshop: Commercialising Nanotechnology – Evolution or Revolution?

Chair: David Tolfree, Vice President of MANCEF, UK

15.30 - 15.55

‘How to Make a Successful Diagnostic Product from MNT’

Dr Andrew Campitelli, MiniFAB (AUST) Pty Ltd, Australia

16.00 - 16.25

'Medimate, Commercialization of a Microfluidic Device to Monitor Lithium in Blood, as a Self Test at Home or at the Doctor's Office’

Steven Staal, Medimate BV, The Netherlands

16.30 - 16.55

‘Microfluidics for Medical Diagnostics, Opportunities and Barriers for Commercialization’

Henne van Heeren, Enabling MNT, The Netherlands

17.00 - 17.30 Panel Discussion
17.30 Close of Day 1

 

Date: 27th November 2008
09.30 - 09.55 Welcome: Professor Shervanthi Homer-Vanniasinkam, Consultant Vascular Surgeon, Leeds General Infirmary Professor of Translational Vascular Medicine, Leeds Medical School

Plenary Session: Medical Nanotechnology- Challenges and Opportunities

Chair: Professor Shervanthi Homer-Vanniasinkam, Consultant Vascular Surgeon, Leeds General Infirmary Professor of Translational Vascular Medicine, Leeds Medical School

10.00 - 10.30

‘Is Regenerative Medicine Ready for Translation onto Clinical Products?’

Prof. Dame Julia Polak, Director, Tissue Engineering and Regenerative Medicine Centre, Imperial College London

10.35 - 11.00

Nanomedicine: Changing the Future of Healthcare

Dr. Franklin Schuling, Sector Head/Focal Area Owner, Molecular & Nuclear Medicine
Philips Research Europe, The Netherlands

11.05 - 11.30

Micro and Nano biosystems in the European Union Research Framework Programs

Francisco Javier Bonal Villanova, European Commission, Belgium

11.35 - 12.00 Refreshments

Session 4: Novel Devices, Nanosensors and Diagnostics

Chair: Prof. Mehdi Tavakoli, Health Technologies KTN, TWI Ltd, UK

12.05 - 12.30

Lab-on-a-Chip as a Tool In the Biomedical Sciences

Prof. Jonathan M. Cooper, FREng, FRSE "Professor of Bioelectronics and Bioengineering, Department of Electronics, University of Glasgow, UK

12.35 - 13.00

‘Sensors Based on Miniature Bridges, Diving Boards and Lids’

Prof. Anja Boisen, Section Leader of NanoSystems Engineering (NSE), Project Leader: Nanoprobes, Technical University of Denmark, DTU Nanotech - Department of Micro- and Nanotechnology

13.05 - 14.25 Lunch
Session 5: Cancer, Congenital and Degenerative disease

Chair: Prof. Dame Julia Polak, Director, Tissue Engineering and Regenarative Medicine Centre, Inperial College London, UK
14.30 - 14.55

‘Foresighting 21st Century Medicine: Anticipating on Technology Options and their Embedment in Healthcare Practices’

Douglas Robinson, University of Twente, Netherlands

15.00 - 15.25

‘Fighting Cancer with Magnetic Nanoparticles'

Andreas Jordan, Magforce Nanotechnologies

15.30 - 15.55

‘The Future of Intelligent Neuroprosthetic Implants'

Prof. Rolf Eckmiller (Emeritus), Professor and Head, Div. Neural Computation, Dept. Computer Science, University of Bonn, Germany

16.00 Conference close

 

For further information contact Carrie Smith, carrie.smith@nano.org.uk

Feedback | Privacy Policy | Terms of Use | © 2008 Institute of Nanotechnology